PATENT CLAIM ANALYSIS

Application Number: 16176743
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["424", "204100"]

Abstract:
Immunogenic influenza hemagglutinin-derived peptide compositions described herein induce a specific therapeutic antibody response against influenza virus. The immunogenic peptide compositions comprise a segment from the fusion initiation region (FIR) domain of an influenza hemagglutinin protein bound to an immunogenic carrier protein, such as an influenza hemagglutinin (HA) protein (i.e., full length HA), and the like. The immunogenic peptide compositions described herein can be utilized to treat or prevent influenza infection and to prepare influenza-specific therapeutic antibodies that interfere with influenza virus-host cell membrane fusion. The peptide conjugates can be formulated in pharmaceutical compositions useful for broad spectrum treatment or prevention of influenza infections

Claim (Index 17):
A method of inhibiting fusion of an influenza virus with the membrane of a host cell in a subject comprising administering the immunogenic peptide composition of  claim 1  to the subject.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 97.0
- Lexical Diversity: 1.59722
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15591386', '13828988', '13579845', '15616615', '12452240']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.725353611484319
- 35 USC 102 Novelty (BERT): 0.5792324679035096
- Combined Prediction Score: 0.7107414971262381
- Mean Citation Score: 371.921666
- Max Citation Score: 491.4173
- Similarity Product: 419.981428412354

Labels:
- Claim Label 101: 0
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test